Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

Abstract

Visfatin, a new adipokine, facilitates adipogenesis and has insulin-mimetic properties. We aimed to investigate the plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus (T2DM) and impaired glucose tolerance (IGT), who had no obesity or hypertension. Twenty-two patients with T2DM, 18 subjects with IGT and 40 healthy… (More)

Topics

Cite this paper

@article{Doru2007PlasmaVL, title={Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.}, author={Teoman Doğru and Alper S{\~o}nmez and Ilker Tasci and Ergun Bozoglu and Mahmut Yilmaz and Halil Genç and Gokhan Erdem and Mahmut Gok and Necati Bingol and Selim Kiliç and Taner Ozgurtas and Sezin Bingol}, journal={Diabetes research and clinical practice}, year={2007}, volume={76 1}, pages={24-9} }